Nuclear medicine vendor ADAC Laboratories (Hall B, #6711) is promising a new product announcement for the meeting but is planning to keep the news to itself until the show. One new product the Milpitas, CA-based company is talking about is WebView, a
Nuclear medicine vendor ADAC Laboratories (Hall B, #6711) is promising a new product announcement for the meeting but is planning to keep the news to itself until the show. One new product the Milpitas, CA-based company is talking about is WebView, a work-in-progress workstation that enables physicians to interpret and process images in their departments, homes, or offices.
General-purpose and specialized SPECT and cardiac displays have been built into WebView. In addition to nuclear medicine studies, WebView supports multimodality images via the DICOM 3.0 standard. The software runs on Windows NT and Windows 95 operating systems.
ADAC will also discuss MCD/AC, the company's high-energy Molecular Coincidence Detection upgrade package with attenuation correction capabilities. MCD/AC uses an external cesium-137 radioactive source to create an attenuation map of tissue densities in the body, and this map is used to compensate for artifacts created by tissue, bone, and other obstructions (SCAN 6/25/97).
MCD/AC improves the visualization of organs and structures deep in the body and could help extend coincidence detection from oncology applications into cardiology uses. MCD/AC received 510(k) clearance in October.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.